MedTrace Logo

Investigation of the Presence of Piriformis Syndrome Accompanying Lumbar Radiculopathy

NCT05392933 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2024-07-08

No results posted yet for this study

Summary

Piriformis syndrome is a neuromuscular disorder that is characterized by piriformis muscle tenderness, hip, and leg pain, and may be accompanied by compression or irritation of the sciatic nerve under the piriformis muscle. There are many studies in the literature to establish diagnostic criteria for piriformis syndrome, and there is still no clear consensus on these criteria. However, cases with lumbar radiculopathy were accepted as exclusion criteria in all these studies. The aim of our study is to investigate whether lumbar radiculopathy and piriformis syndrome can coexist. For this reason, a diagnostic piriformis muscle injection under ultrasonography guidance is planned for patients with lumbar radiculopathy who also have a prediagnosis of piriformis syndrome clinically.

Conditions

  • Piriformis Syndrome
  • Lumbar Radiculopathy

Interventions

DIAGNOSTIC_TEST

Ultrasound guided piriformis muscle lidocaine injection

Ultrasound guided piriformis muscle (piriformis syndrome) 5 ml %2 lidocaine injection

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Yasar Burak Topcu · Istanbul University - Cerrahpasa

  • Tugce Ozekli Misirlioglu · Istanbul University - Cerrahpasa

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-15
Primary Completion
2024-01-15
Completion
2024-06-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05392933 on ClinicalTrials.gov